Login
$KYMR
$114.84 +$4.08 (3.68%) Close

Company Executives

$KYMR Management Team

Dr. Jeremy Chadwick

Chief Operating Officer

Age 62
Compensation $3.462M USD
Sex Male

Dr. Jared Gollob

Chief Medical Officer

Age 61
Compensation $5.750M USD
Sex Male

Mr. Noah Goodman

Chief Business Officer

Age 38
Compensation -
Sex Male

Mr. Brian Adams

Chief Legal Officer

Corporate Secretary

Age 51
Compensation -
Sex Male

Dr. Bruce Booth

Independent Chairman of the Board

Co-Founder

Age 50
Compensation $372.7K USD
Sex Male

Dr. Nello Mainolfi

President

Chief Executive Officer

Co-Founder

Director

Age 46
Compensation $15.43M USD
Sex Male

Mr. Bruce Jacobs

Chief Financial Officer

Age 55
Compensation $7.141M USD
Sex Male

Ms. Justine Koenigsberg

Vice President - Investor Relations

Age -
Compensation -
Sex Female
Directors
9
serving now
Independent
8 of 9
stated in the proxy
Average tenure
5.7 years
from year joined
CEO also chairs the board
No
Bruce Booth
Director Age On board Independent Committees Other public boards Pay Source
Bruce Booth
51 2015
11 years
Independent None stated Sionna Therapeutics, Inc. Not stated
Nello Mainolfi
47 2019
7 years
Not independent None stated None stated Paid as CEO
John Maraganore
63 2022
4 years
Independent
Compensation Committee
Beam Therapeutics Inc., Rapport Therapeutics, Inc., Takeda Pharmaceuticals Not stated
Elena Ridloff
46 2021
5 years
Independent None stated None stated Not stated
Pamela Esposito
52 2020
6 years
Independent None stated Sapience Therapeutics, Inc., Accent Therapeutics, Inc. Not stated
Gorjan Hrustanovic
37 2020
6 years
Independent
Nominating and Corporate Governance Committee
Olema Pharmaceuticals, Inc. Not stated
Victor Sandor
59 2022
4 years
Independent None stated Prelude Therapeutics Incorporated, ADCT Therapeutics SA Not stated
Jeffrey Albers
54 2020
6 years
Independent
Audit Committee
Spyre Therapeutics Not stated
Felix J. Baker
57 2024
2 years
Independent
Compensation Committee
Bicycle Therapeutics PLC, Kodiak Sciences, Inc., Kiniksa Pharmaceuticals International, plc Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support